224
Participants
Start Date
May 15, 2025
Primary Completion Date
May 15, 2027
Study Completion Date
May 15, 2027
NxiDIME™ Intracranial Drug-Eluting Stent System
The experimental group will receive the NxiDIME™ Intracranial Drug-Eluting self-expanding Stent System (RICOTON Technology Co., Ltd.)
NOVA DES Intracranial Drug-Eluting Stent
The experimental group will receive the NOVA DES Intracranial Drug-Eluting balloon-expandable stent System
RECRUITING
A prospective, multi-center, randomized controlled, non-inferiority clinical trial to evaluate the safety and efficacy of the NxiDIME™ Intracranial Drug-Eluting Stent System in the treatment of symptomatic intracranial atherosclerotic stenosis lesions, Beijing
Beijing Tiantan Hospital
OTHER